Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share News

1234567

UK WINNERS & LOSERS: Oxford Instruments Falls On Another Warning

22nd Jan 2015 11:19

Read More

ImmuPharma Shares Up 22% On Simbec-Orion Lupuzor Agreement

22nd Jan 2015 08:32

Read More

UK MIDDAY BRIEFING: GKN A Winner As Earnings Season Hits Full Swing

21st Oct 2014 11:19

Read More

UK WINNERS & LOSERS: ASOS Back In Style Despite Profit Fall

21st Oct 2014 11:00

Read More

ImmuPharma Gets EUR400,000 Grant In France For Urelix Technology

20th Oct 2014 06:59

Read More

ImmuPharma Poised For Phase III Trials Of Lupuzor As Loss As Expected

30th Sep 2014 09:27

Read More

ImmuPharma Forms European Research Team As Part Of Peptides Drive

27th Jun 2014 12:10

Read More

ImmuPharma Granted New US Patent For Nucant Cancer Treatments

16th Jun 2014 10:52

LONDON (Alliance News) - ImmuPharma PLC said Monday that it had been granted a US patent for a new "optically pure" version of its Nucant family of cancer treatments, providing it with longer exclusivity over the product, and expanding their potential uses to related conditions such as age-relate Read More

ImmuPharma Losses Widen As It Accelerates Research And Development

21st May 2014 11:45

LONDON (Alliance News) - Specialist drug discovery and development company ImmuPharma PLC Wednesday said it losses widened in 2013, as its invests in developing its lupus and cancer treatments. The company posted pretax profit loss of GBP4.4 million for 2013, compared with a GBP4.2 million Read More

ImmuPharma Narrows Losses, Developing Lupus Treatment

27th Sep 2013 12:23

Read More

1234567
FTSE 100 Latest
Value8,809.74
Change53.53